Clinical Trials Logo

Recurrent Laryngeal Cancer clinical trials

View clinical trials related to Recurrent Laryngeal Cancer.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02849314 Completed - Clinical trials for Recurrent Laryngeal Cancer

Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer

Start date: July 1, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is the safety and efficacy of cryosurgery plus NK immunotherapy to recurrent laryngeal cancer.

NCT ID: NCT01806675 Completed - Clinical trials for Unspecified Adult Solid Tumor, Protocol Specific

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Start date: March 4, 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is to conduct research of a new PET radiopharmaceutical in cancer patients. The uptake of the novel radiopharmaceutical 18F-FPPRGD2 will be assessed in study participants with glioblastoma multiforme (GBM), gynecological cancers, and renal cell carcinoma (RCC) who are receiving antiangiogenesis treatment.